Safe and Effective Use of Eribulin in Metastatic Breast Cancer

A review of five case studies of women with MBC who were managed successfully with eribulin mesylate after at least two chemotherapeutic regimens.

Navigating nonclinical patient care: A review of chaplaincy

A novel study examines perceptions of the role of the hospital chaplain. What do they do? When should they be called in?

Social Media Survey

ONA would like to know how you use social media services to make sure we’re effectively delivering the content you love.

Natural killer cells battle pediatric leukemia

Immune-system cells from patients with leukemia can be multiplied in the lab, creating a horde of killer cells that can be used to target cancer.

Tighter control coming on on narcotic painkillers

The U.S. Drug Enforcement Administration to enact tough new controls on painkillers containing hydrocodone, which has been tied to a surge in addictions.

Existing drug offers new hope in a subtype of pancreatic cancer

A new use for an old drug shrinks a particular type of pancreatic cancer and stops it from spreading, according to new research.

Complementary and alternative medicine

Have you visited our new section dedicated to biologic treatments, body-based practices, mind-body methods, and alternate medical systems?


Radiation and Your Patient

High-dose rate brachytherapy: From adjuvant therapy to an alternative for prostate cancer

High-dose-rate (HDR) brachytherapy is typically used as a dose-escalating boost for external beam radiotherapy for prostate cancer; however, some researchers believe it might be close to graduating to a viable monotherapy.


Latest News

'Overdiagnosis' in breast cancer screening is still not understood

One-third of women who are given information about the potential for over-diagnosis through the National Health Services (NHS) breast screening program may not completely understand the risks involved.

Lifestyle and genetics strongly impact biomarkers for inflammation and cancer

Genetics and lifestyle influence protein levels in the bloodstream, and this discovery greatly influences the possibilities for using more biomarkers to identify disease.

Irinotecan promising in some patients with stage III colon cancer

A subset of patients with stage III colon cancer had improved survival rates when treated with irinotecan-based therapy, according to recent research.

For black men with prostate cancer, watchful waiting may be unwise

For men with early-stage prostate cancer, watching waiting is not always the best course of action, especially for black patients.

Screening women over age 70 for breast cancer may lead to overdiagnosis

Screening women for breast cancer up to age 75 may lead to overdiagnosis and overtreatment.

For patients with advanced cervical cancer, cisplatin plus pemetrexed may be effective

Cisplatin plus pemetrexed improved response rates and survival rates of patients with advanced cervical cancer.

Fact Sheets

Surgery to Reduce the Risk of Breast Cancer (Fact Sheet)

Surgery to Reduce the Risk of Breast Cancer (Fact Sheet)

This fact sheet examines the potential pros and cons of surgery as a means to reduce breast cancer risk.

Secondhand Smoke and Cancer (Fact Sheet)

Secondhand Smoke and Cancer (Fact Sheet)

This fact sheet examines the relationship between secondhand smoke and cancer risk.

Editorial Board

Ann J. Brady, MSN, RN-BC

Jia Conway, DNP, FNP-BC, AOCNP, NP-C

Michele M. Farrington, BSN, RN, CPHON

Donald R. Fleming, MD

Arati Jairam-Thodla, MSN, CNP

Karen MacDonald, RN, BSN, CPON

Marlene McGuire, RN, MA, ANP-C

Kerstin L. McSteen, BSN, MSN, ACHPN, CNS-BC

Helen H. Miller, LCSW, ACSW

Maribel Pereiras, PharmD, BCPS, BCOP

Leah A. Scaramuzzo, MSN, RN-BC, AOCN

Lisa A. Thompson, PharmD, BCOP

Rosemarie A. Tucci, RN, MSN, AOCN


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs